References
- Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, et al.
Epidemiologic and clinical characteristics of novel coronavirus
infections involving 13 patients outside Wuhan, China. JAMA 2020;
323,11:1092-1093.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
characteristics of 138 hospitalized patientswith 2019 novel
coronavirus–infected pneumonia in Wuhan, China. JAMA 2020;
323(11):1061-1069.
- Wenzhong Liu, Hualan Li. COVID-19: Attacks the 1-Beta Chain of
Hemoglobin and Captures the Porphyrin to Inhibit Human Heme
Metabolism.
DOI: 10.26434/chemrxiv.12120912.
- Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J
Hematol. 2008; 83:307-310.
- Eguchi
A,
Tsuchiya
K,
Tsukada
M,
Nitta
K. Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He)
in patients at the pre-dialysis stage and in patients on peritoneal
dialysis. Japanese Journal of Nephrology. 2010;
52(2):132-140.
- Thomas C, Thomas L. Biochemical markers and hematologic indices in the
diagnosis of functional iron deficiency. Clin Chem. 2002;
48:1066-1076.
- Fairbanks VF, Beutler E. Iron Deficiency. In: Beutler E, Lichtman MA,
Coller BS, et al. Editors. Williams Hematology, Sixth edition. New
York: McGraw-Hill; 2001. Pp: 447-470.
- Kim JM, Ihm CH, Kim HJ. Evaluation of reticulocyte haemoglobin content
as marker of iron deficiency and predictor of response to intravenous
iron in haemodialysis patients. Int J Lab Hematol. 2008; 30:46-52.
- Bellmann-Weiler R, Lanser L, Barket R, Rangger L, Schapfl A, Schaber
M, et al. Prevalence and Predictive Value of Anemia and Dysregulated
Iron Homeostasis in Patients with COVID-19 Infection. J. Clin. Med.
2020; 9:2429: 1-11.
- Eskeland B, Baerheim A, Ulvik R, Hunskaar S. Influence of mild
infections on iron status parameters in women of reproductive age.
Scand J Prim HealthCare. 2002; 20:50–56.
- Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its
ratio to serum ferritin in the diagnosis of iron deficiency. Blood.
1997; 89:1052–1057.
- Edeas M, Saleh J, Peyssonnaux C. Iron: innocent by stander or vicious
culprit in COVID-19 pathogenesis? Int J InfectDis. Int J InfectDis.
2020; 97: 303–305.
- Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat.
Rev. Microbiol. 2008; 6:541-552.
- Taneri PE, Gómez‑Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa‑Díaz
ZM, et al. Anemia and iron metabolism in COVID-19: a systematic review
and meta-analysis. European Journal of Epidemiology. 202; 35:
763–773.
- Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D, et al. Clinical
characteristics of laboratory confirmed positive cases of SARS-CoV-2
infection in Wuhan, China: A retrospective single center analysis.
Travel Medicine and Infectious Disease 36 (2020) 101606.
https://doi.org/10.1016/j.tmaid.2020.101606.
- Alipour R, Hashemi SH, Mikaeili F. Serum iron level in patients with
COVID-19: a case report study. Int J Res Med Sci. 2020 Jul; 8(7):
2658-2662.
- Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and
hypoxia beyond inflammation. A narrative review. Clinics and Practice.
2020; 10:1271:24-30.
- Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for
severity and mortality in adult COVID-19 inpatients in Wuhan. J
Allergy Clin Immunol. 2020; 146(1):110–8.
- Shah A, Frost JN, Aaron L, Donovan K, Drakesmith H. Collaborators
Systemic hypoferremia and severity of hypoxemic respiratory failure in
COVID-19. Crit Care. 2020;24(1):320. https ://doi.org/10.1186/s1305
4-020-03051-w.